Synthesis and antiproliferative activity of 1H-1,2,3-triazole-4H-chromene-d-glucose hybrid compounds with dual inhibitory activity against EGFR/VEGFR-2 and molecular docking studies

Author:

Nguyen Dinh Thanh1ORCID,Do Son Hai12,Le Thi Huyen1,Nguyen Thi Hanh1,Nguyen Minh Huyen1,Vu Thi Ngoc Bich1,Pham Thi Thu Hien1,Vu Ngoc Toan13,Hoàng Thi Kim Van14,Nguyen Thi Kim Giang12

Affiliation:

1. Faculty of Chemistry, VNU University of Science (Vietnam National University, Ha Noi), 19 Le Thanh Tong, Hoan Kiem, Ha Noi, Vietnam

2. Institute of Science and Technology, Ministry of Public Security of Vietnam, 47 Pham Van Dong, Cau Giay, Ha Noi, Vietnam

3. Institute of New Technology, Military Institute of Science and Technology, 17 Hoang Sam, Cau Giay, Ha Noi, Vietnam

4. Faculty of Chemical Technology, Viet Tri University of Industry, Tien Kien, Lam Thao, Phu Tho, Vietnam

Abstract

1H-1,2,3-Triazole-4H-chromene-d-glucose hybrids were synthesized and screened for their anticancer activity in vitro against MCF-7, HepG2, HeLa and WI-38 cells, and several had dual inhibitions against EGFR/VEGFR-2. IFD, MM-GBSA and MD simulations were also carried out.

Funder

National Foundation for Science and Technology Development

Publisher

Royal Society of Chemistry (RSC)

Subject

Materials Chemistry,General Chemistry,Catalysis

Reference62 articles.

1. WHO, Edition 52, published 10 August 2021, https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---10-august-2021 , (2021)

2. COVID-19 outcomes in patients with cancer and HIV: An analysis of the COVID-19 and Cancer Consortium (CCC19).

3. WHO, WHO report on cancer: Setting priorities, investing wisely and providing care for all, https://apps.who.int/iris/bitstream/handle/10665/330745/9789240001299-eng.pdf , (2020)

4. N. C. I. (N.I.H.), Types of Cancer Treatment, ( https://www.cancer.gov/about-cancer/treatment/types )

5. EGFR, HER2 and VEGF Pathways

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3